Edit
Arcutis Biotherapeutics
https://arcutis.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabLast activity: 10.03.2024
Community Guidelines: Arcutis strives to create informative and engaging online communities that share information in meaningful ways. We welcome and encourage your participation and engagement in thoughtful and respectful discourse.When you engage with Arcutis on Facebook (and any other of Arcutis’ social media channels), you are agreeing to these Community Guidelines in addition to the Terms and Conditions or other legal notices provided by Arcutis and those of Facebook: https://www.arcutis.com/community-guidelines/.
Location: United States, California, Westlake Village
Employees: 51-200
Total raised: $319.5M
Founded date: 2016
Investors 8
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.12.2021 | - | $225M | - |
| 21.10.2019 | Series C | $94.5M | - |
Mentions in press and media 22
| Date | Title | Description | Source |
| 10.03.2024 | Arcutis Presents Late-Breaking Data From INTEGUMENT-PED Phas... | Investigational roflumilast cream 0.05% met the primary endpoint and all secondary endpoints, showin... | einpresswi... |
| 09.03.2024 | New Research Reveals Genomic Profile of Seborrheic Dermatiti... | Findings show that seborrheic dermatitis is a unique inflammatory skin disease with its own molecula... | einpresswi... |
| 05.03.2024 | Arcutis Biotherapeutics Reports Inducement Grants Under Nasd... | - | globenewsw... |
| 04.03.2024 | Arcutis Announces Closing of Public Offering of Common Stock... | WESTLAKE VILLAGE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ... | einpresswi... |
| 21.11.2022 | Arcutis Biotherapeutics Publishes First Environmental, Socia... | Report highlights efforts to advance diversity and inclusion, access to medicine, sustainable busine... | esgnews.co... |
| 26.09.2022 | Arcutis' formulation of old AstraZeneca drug clears an... | Weeks after rolling out its first psoriasis treatment, Arcutis Biotherapeutics is racking... | endpts.com... |
| 08.09.2022 | LifeArc portfolio company Ducentis BioTherapeutics acquired ... | LONDON, UK, 08 September 2022 — LifeArc today announced that its portfolio company Ducentis BioThera... | lifearcven... |
| 08.09.2022 | LifeArc portfolio company Ducentis BioTherapeutics acquired ... | LONDON, UK, 08 September 2022 — LifeArc today announced that its portfolio company Ducentis BioThera... | lifearc.or... |
| 08.09.2022 | VC firm LifeArc sells first portfolio company as dermatitis-... | LifeArc Ventures’ billion-pound investment strategy appears to be paying off, as the British life sc... | fiercebiot... |
| 23.12.2021 | Arcutis Biotherapeutics Secures $225 Million in Non-Dilutive... | - | orbimed.co... |
Show more